| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.057 | 0.3 |